Other Briefings
India’s FTA Network: Updates in 2025
India Briefing provides the latest 2025 update on India’s Free Trade Agreements. As of April 29, India and the US have advanced talks to finalize the India-US Bilateral Trade Agreement (BTA) by Fall 2025.
India Simplifies Air Cargo Imports and Waives Transshipment Fees
India has introduced key trade facilitation measures, including simplified procedures for the temporary import of air cargo containers, waiver of transshipment permit fees, and online filing of transshipment applications.
India and the Netherlands: Trade and Investment Profile
India and the Netherlands continue to enhance their economic ties as officials meet in The Hague on April 28, 2025, to discuss new avenues for boosting bilateral trade and investment between the two countries.
India Must Avoid Trade Shortcuts Amid US-China Tariff Tensions: GTRI
According to a GTRI report released on April 21, 2025, India could benefit from US tariffs on China; however, exporters must follow trade rules compliant with the US customs regulations.
How Indian Exporters Can Offset Trump Tariffs Using US Foreign-Trade Zones
Amid Trump-era tariff tensions, Indian analysts see import-export opportunities via the US Foreign-Trade Zone (FTZ) system, as the central government launches a national help desk to support its domestic traders.
Import and Export Procedures in India
Businesses planning to import or export from India must understand the stages involved in the process, the regulatory framework, and documentation required.
India Gains Temporary Relief as Trump Suspends Reciprocal Tariffs for 90 Days
India receives temporary relief from the 26 percent US import duty as Donald Trump announces a 90-day suspension of reciprocal tariffs on all countries except China on April 9, 2025.
US Hikes Tariff on Indian Imports to 26%: All You Need to Know
The US has announced sweeping tariffs, with a 26 percent duty on Indian products. While key industries like gems and jewelry, textiles, and agriculture are likely to face disruption, India’s pharmaceutical sector remains exempt from these tariffs.
